Introduction
Inflammation involving the uveal tract of the eye is termed uveitis and encompasses a wide range of conditions of importance to public health. Uveitis affects 52 of every 100,000 individuals per year in the United States (Gritz and Wong, 2004) and is estimated to be responsible for 5 to 20% of blindness (Durrani et al., 2004) . Animal models of uveitis have revealed much about the immune response within the eye. In experimental autoimmune uveoretinitis (EAU), ocular inflammation is induced by peripheral immunization with retinal antigens or by adoptive transfer of retinal antigen-specific syngeneic CD4 + T-cells. Animals subsequently develop posterior segment inflammation, with evidence of retinal vasculitis, vitreitis, and retinal and subretinal inflammatory infiltrates (Caspi et al., 1988) . Activation of the complement system is involved in the pathogenesis of EAU (Marak et al., 1979; Sohn et al., 2000; Bardenstein et al., 2001; Read et al., 2006) as evidenced by the marked reduction in severity of disease when C3, the central component of the complement cascade, is deleted or inhibited by treatment with the soluble regulatory protein sCrry (Read et al., 2006) . However, which of the complement anaphylatoxin receptors mediates the pro-inflammatory effects of complement during EAU remains unknown. To address the role of C3a and C5a mediated-inflammation in EAU, we induced disease in C3a receptor −/− (C3aR 
/ C5aR
−/− mice.
Material and methods

Mice
All experiments were carried out with approval of the University of Alabama at Birmingham Institutional Animal Care and Use Committee and adhered to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Generation of C3aR −/− (Kildsgaard et al.,
2000) and C5aR
−/− (Hopken et al., 1996) mice on the C57BL/6 background have been described previously. Inbred C57BL/6 mice, originally from The Jackson Laboratory (Bar Harbor, ME), were from our own colony. C3aR −/− /C5aR −/− mice were generated in our colony by crossing C3aR −/− and C5aR −/− mice. Eyes from all untreated mice appeared phenotypically normal with respect to ocular architecture and anatomy, both grossly and microscopically.
Induction and assessment of EAU
Human interphotoreceptor retinoid binding protein (IRBP) peptide 1-20 (GPTHLFQPSLVLDMAKVLLD) was synthesized using Fmoc chemistry and was N95% pure as determined by reversed phase-HPLC (Biosynthesis, Lewisville, TX). The mice were immunized subcutaneously in the right flank with 500 μg IRBP peptide emulsified in complete Freund's adjuvant (Difco, Detroit, MI) (1:1, vol/vol) supplemented with Mycobacterium tuberculosis strain H37RA (5 mg), and concurrently given 1.5 mg of purified Bordetella pertussis toxin (Sigma Chemical, St. Louis, MO) intraperitoneally (Avichezer et al., 2000) . The eyes were collected from humanely euthanized mice on day 21 after immunization, the peak of disease in the IRBP EAU model (Avichezer et al., 2000) . The freshly enucleated eyes were placed in Journal of Neuroimmunology 264 (2013) 127-129 
